ClinConnect ClinConnect Logo
Search / Trial NCT05872737

FAB Programme for Parents of Children With NDD

Launched by CHINESE UNIVERSITY OF HONG KONG · May 23, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Neurodevelopmental Disorders Facilitator Guided Acceptance And Commitment Bibliotherapy Parental Psychological Health Parenting Stress Repeated Measures Parallel Group Design Randomized Controlled Trial Psychological Flexibility Hong Kong Acceptance And Commitment Therapy

ClinConnect Summary

The FAB Programme is a study designed to help parents of young children with neurodevelopmental disorders (NDD), such as Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder. This program uses a special therapy approach called Facilitator-guided Acceptance and Commitment Bibliotherapy (FAB) to support parents' mental health and improve the emotional and behavioral well-being of their children. The study will include 154 parents who speak Cantonese and have children aged 2 to 6 years old with these diagnoses. Researchers hope to find that this program can help parents develop better coping skills and improve their relationship with their children.

To participate, parents must be at least 21 years old, live in Hong Kong, and care for a child who meets specific diagnosis criteria. They should also have access to the internet. However, parents who have severe mental health issues or difficulties understanding the program due to other disabilities will not be eligible. Participants can expect to engage in guided sessions that focus on enhancing their parenting skills and emotional resilience, which may lead to improved outcomes for both them and their children. This study is currently recruiting participants, and it's a great opportunity for parents looking for support.

Gender

ALL

Eligibility criteria

  • Parents of young children with NDD who fulfil the following criteria will be recruited:
  • Cantonese-speaking Hong Kong residents,
  • aged ≥ 21 years,
  • have a child aged between two and six years old (preschool age) with a clinically documented diagnosis/suspected NDD diagnosis according to DSM-5 criteria (e.g., ASD, ADHD, developmental delay) and enrolled in the SWD subvented pre-school rehabilitation services offered by NGOs,
  • caregivers who adopted the responsibility of taking care of the child, living together with the child, and
  • have device(s) with internet access.
  • Parents of young children with NDD will be excluded if:
  • has been diagnosed with severe mental illness(es),
  • cognitive/language/communication/visual/hearing impairment(s) or disorders that may present difficulties in comprehending the content of the intervention; and/or
  • are currently receiving another psychosocial, psychoeducational, or parenting intervention(s).

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Shatin, , Hong Kong

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported